Related Experiment Video
Updated: Apr 23, 2026

06:32
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
7.0K
Multi-Beholder: Biomarker Prediction for Low-Grade Glioma with Multiple Instance Learning and One-Class
Summary
This study introduces Multi-Beholder, an AI tool that predicts low-grade glioma (LGG) biomarkers from standard tissue slides, simplifying diagnosis and treatment. It offers high accuracy and reveals links between cell appearance and biomarker status.
Area of Science:
- Computational pathology
- Artificial intelligence in oncology
- Molecular diagnostics
Background:
- Biomarker detection is crucial for low-grade glioma (LGG) diagnosis and treatment.
- Current methods involve costly, complex genetic testing with potential for variability.
- There is a need for accessible and reliable biomarker detection in LGG.
Purpose of the Study:
- To develop an interpretable deep learning pipeline, Multi-Beholder, for predicting LGG biomarker status.
- To utilize only hematoxylin and eosin (H&E)-stained whole slide images for biomarker prediction.
- To improve the accuracy and accessibility of biomarker detection in LGG.
Main Methods:
- Developed Multi-Biomarker Histomorphology Discoverer (Multi-Beholder), a deep learning pipeline.
- Integrated one-class classification with multiple instance learning for pseudo-labeling.
- Validated the pipeline on TCGA-LGG and Xiangya cohorts using H&E whole slide images.
Main Results:
- Multi-Beholder achieved high prediction performance, with an Area Under the Receiver Operating Characteristic Curve (AUC) up to 0.973 (TCGA-LGG) and 0.820 (Xiangya).
- The pipeline demonstrated interpretability, correlating biomarker status with histomorphology.
- Accurate instance-level pseudo-labeling improved prediction accuracy.
Conclusions:
- Multi-Beholder offers a novel, accurate, and interpretable approach for LGG biomarker prediction from H&E images.
- This method enhances the applicability of molecular treatments for LGG patients.
- The pipeline facilitates discovery of new mechanisms in LGG progression and molecular functionality.

